Alzheimer disease (AD) is characterised by a slowly progressive decline of memory and cognition. Alzheimer described the characteristic cortical senile plaques and neurofibrillary tangles in the brain of a 51-year-old woman with presenile dementia (Refs 1, 2). Because the presenile form, with onset before the age of 65, is identical to the most common form of senile dementia, today, the term AD is used for the designation of both presenile and senile cases (Refs 3, 4). Senile plaques were first described by Blocq and Marinesco (Ref. AD is a form of amyloidosis. The amyloid substance aggregated in the brain is a small, ∼4 kDa amyloid beta peptide (Aβ). It is released by β-and γ-secretase cleavage from a larger 120 kDa transmembrane amyloid precursor protein (APP) (Refs 10, 11) and was purified and partially sequenced by Glenner and Wong (Ref. 12) . APP exhibits features of a glycosylated cell-surface receptor and was shown to be a proteoglycan core protein (Ref. 13) . APP is phylogenetically highly conserved and constitutively expressed by various cells other than neurons, including immune cells (Ref. 14) . Human platelets, peripheral lymphocytes and leukocytes produce the major isoforms of APP, and after activation, they secrete amyloidogenic Aβ (Refs 15, 16, 17, 18).
Aβ has a higher ability to aggregate than the shorter Aβ (Refs 19, 20) . Aβ exists in soluble nontoxic monomers, strongly toxic soluble oligomers and in the form of less toxic insoluble fibrils. The soluble oligomers of Aβ Presenilin-2 (PS2) mutations are responsible for another subset of early-onset familial AD (Refs 47, 51). As originally shown by Hardy (Ref. 39), mutations in these pathogenic genes alter the processing of APP and result in an increase in amyloidogenic Aβ and Aβ (Refs 50, 52, 53, 54, 55, 56, 57, 58, 59) . The epsilon 4 allele of apolipoprotein E (APOE ε4) is an important risk factor for late-onset AD, which also correlates with increased Aβ burden (Ref. 60) . Finally, there is an association between AD and polymorphisms of various other genes, which include a growing number of genes, implicated in immune defence mechanisms (Refs 61, 62) .
The relation between the two major biological markers of AD, Aβ (Refs 38, 41) and hyperphosphorylated tau (Refs 34, 35), is not clear. Soluble Aβ and tau strongly interact (Ref. 63) , and APP is expressed in neurofibrillary tangles (Ref. 64 ), suggesting that these apparently different pathologies are linked.
Alterations of various neurotransmitters, neuropeptides and hormones are reported to occur in AD ( Refs 65, 66, 67, 68) . The cholinergic hypothesis is based on the alteration of acetylcholine synthesis, transport and release (Refs 69, 70) . Oxidative damage to proteins, lipids and nucleic acids (Refs 71, 72, 73, 74) Other authors found no evidence of spirochetes in the brains of seven AD cases by dark-field or electron microscopy (Ref. 192) . However, spirochetes were observed in the blood of one of 22 living patients with AD-type dementia ( Table 1 ). The spirochete observed by these authors corresponded to the vegetative, regularly spiral form. They suggested that it could correspond to an oral spirochete. Whether the atypical, pleomorphic spirochetal forms, which commonly occur in infected tissues, blood and CSF (Refs 167, 175, 177, 193) , were considered by the authors is not clear.
Periodontal pathogen Treponemas
Using molecular and immunological techniques, six of seven periodontal Treponema species, namely T. socranskii, T. pectinovorum, T. denticola, T. medium, T. amylovorum and T. maltophilum, were identified in the brains of AD patients using species-specific polymerase chain reaction (PCR; Table 1 ). At least one oral Treponema species was present in 14 of 16 AD brains, compared with 4 out of 18 controls (Ref. 147) . T. pectinovorum and T. socranskii antigens were observed in 15 of 16 AD brains and in 7 of 18 controls. In the hippocampus and in the frontal cortex. Six different Treponema species were detected in one AD patient, five species in four, four or three species each in one AD case, and one species in seven AD brains. Two Treponema species were observed in one control and one species in the other three positive controls. These results reinforce previous observations (Ref. 146 ) and indicate that these periodontal pathogen spirochetes, in an identical way to T. pallidum and B. burgdorferi, have the ability to invade the brain, persist in the brain, and cause dementia, cortical atrophy and amyloid deposition. Cases from previous studies, which were subtracted when the total number of cases of studies was considered. individuals. Dementia and subacute presenile dementia both occur in Lyme disease (Refs 146, 149, 194, 195, 196, 197, 198) . B. burgdorferi was first detected in the brains of two AD patients ( (Table 1) . Similarly, the analysis of the serology of B. burgdorferi alone, as a result of the low incidence of Lyme dementia compared with AD, might give false-negative results (Refs 180, 182) . To demonstrate the role of B. burgdorferi, AD patients with Lyme neuroborreliosis should be analysed.
Taken together, these observations show that various authors detected and cultivated various types of spirochetes from the brains of AD patients. Coinfection with several types of spirochetes occurs.
Chlamydophyla pneumoniae
Several authors reported the existence of an association between C. pneumoniae, an obligate intracellular respiratory pathogen, and AD ( Refs 144, 200, 201, 202, 203) (Table 2 ). C. pneumoniae-specific DNA was detected in the brains in 90% of sporadic AD patients and in 5% of controls (Ref. 144) ( Table 2) . Two mRNAs, encoding KDO transferase and a 376 kDa protein, specific to C. pneumoniae, were also identified in frozen AD brain tissue by reverse transcriptase-PCR (RT-PCR).
Immunohistochemical analyses of AD brains showed C. pneumoniae in microglia, perivascular macrophages and astrocytes, and in about 20% of neurons (Refs 144, 200, 201, 203, 207, 211) . They were commonly found in brain regions showing the characteristic neuropathology of AD (Refs 144, 200, 201) . The presence of C. pneumoniae in the brains of AD patients was also confirmed by immunoelectron microscopy using specific monoclonal antibody against the outer membrane protein of C. pneumoniae. Electron and immunoelectron microscopy identified both chlamydial elementary bodies and reticulate bodies (RBs) (Refs 212, 144) . That the replicative RB form was also detected in glial cells, neurons and pericytes indicates that a viable and transcriptionally active form of the microorganism is present in these cells (Refs 201, 213, 214, 215) . Pleomorphic forms of C. pneumoniae were also observed (Ref. 
Other bacteria
Propionibacterium acnes, an atypical anaerobic bacterium, was identified in biopsy specimens of the frontal cortex in three of four AD patients and in one of five controls with cerebral tumour. The P. acnes positive control was an elderly patient with cardiovascular risk factors and glioblastoma (Ref. 205) . P. acnes was identified by microbiological methods and by gas chromatography. The bacterium was cultivated from frontal cortical biopsy specimens in Schaedler blood agar, at 35°C, under anaerobic conditions (Refs 205, 206) . P. acnes has long been considered to be a commensal bacillus of the skin. Recent observations showed that P. acnes, the causative agent of acne vulgaris, is implicated in various infections, including brain abscesses, endocarditis, endophthalmitis and osteomyelitis (Refs 208, 209) . P. acnes was also shown to be a predominant periodontal pathogen (Ref. 218) . By haematogenous dissemination, it can reach and infect various organs, including the brain. Stabilisation of the clinical symptoms and memory improvement were observed in two AD cases treated with P. acnes-sensitive cephalosporine combined with enalapril and oestrogen (Ref. 206) . The author pointed to microangiopathy as the underlying pathology (Refs 219, 220). Because the number of AD cases analysed is low, further studies should be encouraged to determine any association of P. acnes with AD.
Actinomycetes have also been suggested to be involved in AD, with an incidence four times Anti-HSV-1 antibodies as detected in the CSF by enzyme-linked immunosorbent assay (ELISA) were also significantly higher in AD patients than in younger controls, but without a significant difference between the AD and age-matched control groups (Ref. 242) . Increased titres of HSV-1 IgGs, which characterise past infection, were observed in AD cases and age-matched controls, without a significant difference between the two groups (Refs 243, 244). In a large prospective study, in addition to HSV-1 IgG, the presence of IgM, which characterises active primary infection or reactivation of the infection, was also assessed in the sera of 512 elderly patients, initially free of dementia. During 14 years of follow-up, 77 AD cases were diagnosed. In contrast to IgG, IgM-positive subjects showed a significantly higher risk of developing AD, indicating that reactivation of HSV-1 seropositivity is correlated with AD (Ref. 245) .
Other herpes viruses were also detected in the brain using PCR: human herpes virus 6 (HHV6) types A and B, herpes simplex virus type-2 (HSV-2) and cytomegalovirus (CMV). HHV6, HSV-2 and CMV were observed in 70%, 13% and 36% of AD patients and in 40%, 20% and 35% of controls, respectively. The differences between the groups were not statistically significant (Ref. 246) .
In addition to CMV, a possible association between HLA-BW15 and AD has also been reported (Ref. 247) . A recent study revealed that elderly subjects with high levels of antibody against CMV develop more severe cognitive decline over 4 years (Ref. 248 
Correlates of infection risk and AD
Based on the data available on the association of spirochetes, C. pneumoniae and HSV-1 with AD, contingency tables were used to analyse the strength of the association and the risk of infection in AD. In those studies where all types of spirochetes were detected using neutral techniques, spirochetes were observed in the brain in 90.1% (64/71) of AD cases and were absent in controls without any AD-type changes. This difference is significant (Table 1) , and the association remains significant when cases where spirochetes were analysed in the blood are also included. The association between periodontal pathogen spirochetes and AD is also statistically significant. They were detected in the brain in 93.7% of AD cases and in 33.3% of controls. B. burgdorferi was about 13 times more frequent in AD cases than in controls, a statistically significant difference. It is noteworthy that B. burgdorferi was detected in all AD cases with a positive serology or where spirochetes were cultivated from the brain ( Table 1) . Taken together, in all studies where spirochetes or their specific species (periodontal Treponema spirochetes or B. burgdorferi) were detected in the brain, it can be concluded that the frequency of spirochetes is more than eight times higher in AD cases (90/131; 68.7%) than in controls (6/71; 8.41%). That spirochetes were cultivated from the brains of AD patients indicates that viable spirochetes are present in advanced stages of dementia. They can sustain persisting infection and inflammation and cause neuronal destruction (Ref. 148 ).
The frequency of C. pneumoniae was about five times higher in AD cases (60/125; 48%) than in controls (5/52; 9.6%). The difference remains significant when those cases where C. pneumoniae was detected in the CSF were also included ( 
Evidence for underlying mechanisms Sources and dissemination
Spirochetes, C. pneumoniae and HSV-1 are all able to invade the brain (Fig. 3) Through infected circulating monocytes, C. pneumoniae can also spread by haematogenous dissemination and, by crossing the blood-brain barrier, infect the brain. C. pneumoniae is an upper respiratory tract pathogen and can reach the brain through the olfactory system (Ref. (Fig. 4) . The core pathway activated by most TLRs leads to the activation of transcription factor nuclear factor-kappa B (NF-κB) and the mitogen-activated protein kinases (MAPKs) p38 and Jun kinase (JNK). The second pathway is activated by TLR3 and TLR4 and results in the activation of both NF-κB and interferon regulatory factor-3 (IRF3), allowing the induction of another set of inflammatory genes, including the antiviral interferon-β gene (IFNB).
Neuroinflammation and TLR signalling
Activation of p38 MAPKs during bacterial infection was also shown to be crucial in the local production of cytokines such as IL-8 (Ref. 295) 
Evasion and establishment of latent and chronic infection
The ability of spirochetes and C. pneumoniae to evade destruction by host immune systems and establish chronic infection is well known. HSV-1 can also remain in a latent state and persist throughout life in human tissues. In the latent state, the viral genome is present, but no viral particles are produced. Viral gene expression during latency is limited to one locus -the gene encoding the latency-associated transcript (Ref. 151 ).
Pathogens use a broad range of strategies to overcome antigenic recognition, complement lysis and phagocytosis. Blockade of the complement cascade or acquisition of hostderived complement inhibitors results in their evasion from complement lysis. This allows microbial survival and proliferation even in immune-competent hosts. Complement-resistant strains of B. burgdorferi possess five complement regulatory acquiring surface proteins, which bind host complement inhibitors (Refs 307, 322) and a CD59-like molecule (Refs 322, 323) . A fragment of HSV-1 glycoprotein C (gC) shares sequence similarity with host complement receptor 1 (CR1), showing that viruses can also escape from attack by the MAC. Bacteria and viruses protect themselves from destruction by the host adaptive immune system. B. burgdorferi induces IL-12, a cytokine recently recognised to be critical for driving cellular responses towards the Th1 subset of T helper cells (Refs 293, 324) . This shift retards antibody induction by Th2 cells against bacteria. These various ways of evasion allow bacteria to survive and proliferate in host tissues and sustain chronic infection. Macrophage regulation of immune surveillance involves iron depletion (Refs 330, 331, 332) . Lactoferrin, which is similar in structure to transferrin, has a role in natural defence mechanisms in mammals and is upregulated in neurodegenerative disorders. Lactoferrin exerts its anti-inflammatory action by inhibiting hydroxyl radical formation. This antioxidant property prevents DNA damage (Ref. 
Iron and nitric oxide

Amyloidogenesis
Amyloidogenesis is the aggregation of soluble proteins into detergent-insoluble filamentous structures about 10 nm wide and 0.1-10 μm long. These amyloid fibrils have distinct biochemical and biophysical properties, including resistance to proteinase K treatment, β-sheet structure and affinity for binding thioflavin S and Congo Red.
Chronic bacterial infections (e.g. rheumatoid arthritis, leprosy, tuberculosis, syphilis, osteomyelitis) are frequently associated with amyloid deposition. Cortical and vascular amyloid deposition in the atrophic form of general paresis, caused by a spirochete (T. pallidum), as in AD, corresponds to Aβ.
On the basis of previous observations, it has been suggested that amyloidogenic proteins might be an integral part of spirochetes and can contribute to Aβ deposition in AD (Ref. 
Genetic factors
Host responses to bacterial infections are genetically controlled. Promoter polymorphisms in the genes of proinflammatory cytokines are associated with susceptibility to infection (Ref. 352) . Tumour necrosis factor alpha (TNF-α) is a critical mediator of host defence against infection. Polymorphisms in the gene encoding TNF-α might determine a strong cell-mediated immune response or a weak or absent cellular response, which reflects the genetic variability in cytokine production (Refs 352, 353 61, 358, 359, 360, 361, 362) .
Association between AD pathology and IL-1β expression patterns (Ref. 363) , and between disease risk and IL-1β gene polymorphisms, has been reported ( Refs 62, 364) . Genetic variation in the expression of microbial PRRs, including TLRs, and CD14 gene polymorphisms predispose to various infections and are also associated with AD (Refs 365, 366).
Genetic mutations in APP, PS1 and PS2 are related to the processing of APP (Ref. 39). Because APP has an important role in the regulation of immune system reactions and in Tcell differentiation (Refs 16, 17, 18), genetic defects in such genes should also result in increased susceptibility to infection.
APOE ε4 enhances the expression of inflammatory mediators (Refs 367, 368) and has a modulatory function in susceptibility to infection by various bacteria, viruses and protozoa (Refs 367, 368, 369, 370, 371, 372) . APOE genotyping of three AD cases, where B.
burgdorferi was detected and cultivated from the brain, showed that two of them were APOE ε4 carriers. The low number of cases does not allow any conclusion for an eventual link between spirochetal infection and the APOE ε4 allele (Ref. 
Outstanding research questions and conclusions
The analysis of all positive and negative data available in the literature on the association of pathogens with AD indicates a statistically significant association between various types of spirochetes, C. pneumoniae and AD. There is no significant difference between the frequency of HSV-1 in AD cases compared with age-matched controls. However, several authors found a significant difference between the frequencies of HSV-1 in APOE ε4 carriers and noncarriers. The occurrence of positive anti-HSV-1 IgM was reported to be a risk factor for AD (for a recent review, see Ref. 373) .
Lesions that are similar to senile plaques, neurofibrillary tangles and neuropil threads, and granulovacuolar degeneration, accumulation of Aβ, increased APP levels and phosphorylation of tau have all been induced by exposure of mammalian neuronal and glial cells and CNS organotypic cultures to spirochetes. Aβ-positive plaques were induced by inhalation of C. pneumoniae in mice in vivo, and exposure to HSV-1 increased the Aβ level and produced tau phosphorylation in neurons in vitro and in vivo.
Through TLRs and other PRRs, pathogens or their toxic components induce gene expression and activation of proinflammatory molecules by host cells. Both the classical and alternative complement pathways are activated in AD. MAC(C5b-9), which is intended to lyse bacteria or encapsulated viruses, and activated microglia that are designed to clean up debris and foreign bacteria are both associated with cortical AD lesions.
Evasion of pathogens from host defence reactions results in sustained infection and inflammation. The microorganisms and their toxic components can be observed in affected brains, along with host immunological responses.
Spirochetes, C. pneumoniae and HSV-1 disseminate from the primary site of infection to the brain usually through systemic infection. As in syphilis, systemic infection and inflammation precede the development of dementia by years or decades. Detection of infection in its early, peripheral stage can hamper its dissemination to the CNS and prevent dementia. Consequently, peripheral infections can have a role in the initiation and progression of neurodegeneration in AD ( Refs 146, 374, 375, 376 In conclusion, the data available indicate that infectious agents can initiate the degenerative process in AD, sustain chronic inflammation, and lead to progressive neuronal damage and amyloid deposition. The accumulated knowledge, views and hypotheses proposed to explain the pathogenesis of AD fit well with an infectious origin of the disease. The outcome of infection is determined by the genetic predisposition of the patient, by the virulence and biology of the infecting agent, and by various environmental factors, such as exercise, stress and nutrition.
More attention and support is needed for this emerging field of research. Infection starts long before the manifestation of dementia; therefore, an adequate treatment should start early. Because antibacterial, antiviral and anti-inflammatory therapy is available, as in syphilis, one could prevent and eradicate dementia. The effect on the suffering of patients and on the reduction of healthcare costs would be considerable. Tables  Table 1 . Detection of spirochetes in AD. Table 2 . Detection of Chlamydophyla pneumoniae and other bacteria in AD. Table 3 . Detection of HSV-1 in AD. 
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